GreenSky Principal Greg Stewart named Chairman of Mirexus Board

Toronto, ON – October 8, 2015

The GreenSky Accelerator Fund I, LP (“the Fund”) is excited to announce that it has closed an investment with Mirexus Biotechnologies Inc. The Fund participated in the $4.5M syndicate alongside Barbados-based Goddard Enterprises Ltd., Asahi Kasei Corporation, a Japanese firm focused on materials with US$18 billion revenue, and existing investors.

Mirexus is a safe and natural nanomaterials company based in Guelph, Ontario that is commercializing PhytoSpherix™, a novel technology based on polysaccharide nanoparticles that can be used in a wide variety of markets ranging from cosmetics to nutraceuticals to applications in human health. Early indications suggest that, amongst many exceptional properties, PhytoSpherix’s is the world’s most effective moisturizer.

GreenSky Capital Inc., a registered Ontario exempt market dealer that is affiliated with the Fund, was instrumental in providing Mirexus with its seed round capital in early 2014. This seed round was raised largely through the GreenSky President’s Club, an affiliated network of high-net worth active angel investors.

“Our relationship with GreenSky has been extremely rewarding. They have assisted at all of the crucial stages of our evolution with both capital and strategic support,” said Phil Whiting. “There is perhaps no better testament to our relationship than that we have asked Greg Stewart, the President of GreenSky Capital, to become Chairman of Mirexus’s Board.”

Said Stewart, “Mirexus is one of the most exciting start-ups in Ontario. I am looking forward to continued involvement in what has, to date, proven to be an exceptional investment for GreenSky. It has been a pleasure working with Phil, the Board and its advisors, and the first-class team Phil has assembled in a very short time.”

About Mirexus Biotechnologies Inc.
Mirexus Inc. is a safe and natural biomaterials company based in Guelph, Ontario that is commercializing a novel nanotechnology based on polysaccharide nanoparticles that can be used in a wide variety of markets ranging from cosmetics to nutraceuticals to biomedical applications in animal and human health. This technology was originally developed at the University of Guelph in the laboratories of Professor John Dutcher. mirexus.com

About the GreenSky Accelerator Fund
The GreenSky Accelerator Fund is a venture capital fund focused on making seed stage investments in high-growth, early-stage Canadian CleanTech and IT opportunities. Through its affiliation with GreenSky Capital Inc., the GreenSky Accelerator Fund has access to a robust network of deal flow and takes an institutional approach to early stage investing.
For more see: www.greenskycapital.com/greensky-accelerator-fund/